Delivery Order SPE2DB20D3101-SPE2DB25FRTD9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,383.74 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) on September 25, 2025, with completion scheduled for September 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Isotretinoin is a potent oral retinoid primarily used for the treatment of severe acne and...
- The Defense Logistics Agency awarded a delivery order valued at $20,726.74 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) under a firm fixed-price contract. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and is not designated as a set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. Isotretinoin...
- The Defense Logistics Agency awarded a delivery order valued at $2,690.14 to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Isotretinoin is a potent oral retinoid medication primarily used for severe acne treatment, and this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count units) valued at $1,153.95, with a firm fixed price structure and ultimate completion date of September 23, 2025. This competitively awarded, non-set-aside contract represents a continuation order under AmerisourceBergen's existing pharmaceutical supply agreements with DLA. The work will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30 count) with a ceiling value of $1,835.95, effective August 19, 2025, with ultimate completion by August 20, 2025. This firm fixed-price, non-set-aside contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,173.84 to AmerisourceBergen Drug Corp for Isotretinoin 20 mg capsules (30-count units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Isotretinoin is a potent retinoid medication primarily used for severe acne treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $2,868.79 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA. The work will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,107.60 for Isotretinoin 30 mg capsules (30-count units) on September 12, 2025, with a completion date of September 15, 2025. This is a firm fixed price, non-set-aside contract to be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,982.61 on July 30, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 31, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) under a firm fixed-price contract valued at $6,065.50. The order was competitively awarded without a set-aside designation and carries an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child contract...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRTD9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) valued at $18,281.62 under a firm fixed-price contract with no set-aside designation. The contract was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Isotretinoin is a prescription medication primarily used for treating severe acne and related dermatological conditions within military and federal healthcare systems. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement through competitively awarded contracts that provide comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. The company's extensive federal contracting portfolio demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.3k | 8/20/25 |